
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma
Xiaocong Mo, Di Hu, Pingshan Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 48
Xiaocong Mo, Di Hu, Pingshan Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Cuproptosis: mechanisms and links with cancers
Jiaming Xie, Yannan Yang, Yibo Gao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 362
Jiaming Xie, Yannan Yang, Yibo Gao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 362
Crosstalk between metabolism and cell death in tumorigenesis
Shichao Yang, Caden Hu, Xiaomei Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Shichao Yang, Caden Hu, Xiaomei Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 21
Copper homeostasis and cuproptosis in mitochondria
Ziying Tian, Su Jiang, Jieyu Zhou, et al.
Life Sciences (2023) Vol. 334, pp. 122223-122223
Closed Access | Times Cited: 32
Ziying Tian, Su Jiang, Jieyu Zhou, et al.
Life Sciences (2023) Vol. 334, pp. 122223-122223
Closed Access | Times Cited: 32
Role of cuproptosis in understanding diseases
Shihan Cao, Qian Wang, Zhenzhen Sun, et al.
Human Cell (2023) Vol. 36, Iss. 4, pp. 1244-1252
Open Access | Times Cited: 25
Shihan Cao, Qian Wang, Zhenzhen Sun, et al.
Human Cell (2023) Vol. 36, Iss. 4, pp. 1244-1252
Open Access | Times Cited: 25
Construction and validation of a cuproptosis-related prognostic model for glioblastoma
Bohong Zhang, Lin Xie, Jiahao Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Bohong Zhang, Lin Xie, Jiahao Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Multiomics Analysis Reveals Cuproptosis-Related Signature for Evaluating Prognosis and Immunotherapy Efficacy in Colorectal Cancer
Rong He, Heping Zhang, Huaxin Zhao, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 387-387
Open Access | Times Cited: 16
Rong He, Heping Zhang, Huaxin Zhao, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 387-387
Open Access | Times Cited: 16
Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia
Yidong Zhu, Jun He, Zihua Li, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Yidong Zhu, Jun He, Zihua Li, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma
Xiaoran Bai, Fei Lu, Shuying Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Xiaoran Bai, Fei Lu, Shuying Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells
Wei Liu, Yi Yu, Yi He, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Wei Liu, Yi Yu, Yi He, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLC
Yijie Tang, Tianyi Wang, Qixuan Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Yijie Tang, Tianyi Wang, Qixuan Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer
Xifu Cheng, Famin Yang, Yuanheng Li, et al.
Aging (2024) Vol. 16, Iss. 12, pp. 10512-10538
Open Access | Times Cited: 3
Xifu Cheng, Famin Yang, Yuanheng Li, et al.
Aging (2024) Vol. 16, Iss. 12, pp. 10512-10538
Open Access | Times Cited: 3
Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs
Xu Zhang, Zhiqiang Ye, Guohong Xiao, et al.
Computers in Biology and Medicine (2023) Vol. 159, pp. 106905-106905
Closed Access | Times Cited: 9
Xu Zhang, Zhiqiang Ye, Guohong Xiao, et al.
Computers in Biology and Medicine (2023) Vol. 159, pp. 106905-106905
Closed Access | Times Cited: 9
LncRNA PRKCA-AS1 promotes LUAD progression and function as a ceRNA to regulate S100A16 by sponging miR-508-5p
Chaohui Wu, Jiansheng Yang, Xianbin Lin, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1718-1730
Open Access | Times Cited: 2
Chaohui Wu, Jiansheng Yang, Xianbin Lin, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1718-1730
Open Access | Times Cited: 2
Clinical significance and integrative analysis of the cuproptosis-associated genes in head and neck squamous cell carcinoma
Peng Qiu, Xianjie Jiang, Shiming Tan, et al.
Aging (2023) Vol. 15, Iss. 6, pp. 1964-1976
Open Access | Times Cited: 6
Peng Qiu, Xianjie Jiang, Shiming Tan, et al.
Aging (2023) Vol. 15, Iss. 6, pp. 1964-1976
Open Access | Times Cited: 6
Identification and validation of long noncoding RNA AC083900.1 and RP11-283C24.1 for prediction of progression of osteosarcoma
Liangkun Huang, Wenyi Jin, Yucheng Bao, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2023) Vol. 827, pp. 111828-111828
Closed Access | Times Cited: 6
Liangkun Huang, Wenyi Jin, Yucheng Bao, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2023) Vol. 827, pp. 111828-111828
Closed Access | Times Cited: 6
Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma
Peijun Liu, Long Zhou, Hao Chen, et al.
PeerJ (2023) Vol. 11, pp. e16242-e16242
Open Access | Times Cited: 6
Peijun Liu, Long Zhou, Hao Chen, et al.
PeerJ (2023) Vol. 11, pp. e16242-e16242
Open Access | Times Cited: 6
Expression and significance of LncRNA APTR in the occurrence and development of LUAD
Qi Zhao, Xiong Shi, Hourong Cai, et al.
Journal of Environmental Pathology Toxicology and Oncology (2024) Vol. 44, Iss. 1, pp. 11-20
Closed Access | Times Cited: 1
Qi Zhao, Xiong Shi, Hourong Cai, et al.
Journal of Environmental Pathology Toxicology and Oncology (2024) Vol. 44, Iss. 1, pp. 11-20
Closed Access | Times Cited: 1
Construction of a prognostic model for ovarian cancer based on a comprehensive bioinformatics analysis of cuproptosis-associated long non-coding RNA signatures
Rujun Chen, Yating Huang, Ke Sun, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35004-e35004
Open Access | Times Cited: 1
Rujun Chen, Yating Huang, Ke Sun, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35004-e35004
Open Access | Times Cited: 1
Circular RNAs in programmed cell death: Regulation mechanisms and potential clinical applications in cancer: A review
Yudi Gao, Hong Lin, Tiantian Tang, et al.
International Journal of Biological Macromolecules (2024), pp. 135659-135659
Closed Access | Times Cited: 1
Yudi Gao, Hong Lin, Tiantian Tang, et al.
International Journal of Biological Macromolecules (2024), pp. 135659-135659
Closed Access | Times Cited: 1
Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis
Martín Salamini-Montemurri, Mónica Lamas‐Maceiras, Lidia Lorenzo-Catoira, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10798-10798
Open Access | Times Cited: 4
Martín Salamini-Montemurri, Mónica Lamas‐Maceiras, Lidia Lorenzo-Catoira, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10798-10798
Open Access | Times Cited: 4
Comprehensive exploration of the involvement of cuproptosis in tumorigenesis and progression of neuroblastoma
Rui Zhou, Dongmei Huang, Wen Fu, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Rui Zhou, Dongmei Huang, Wen Fu, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma
Mingzhe Li, Qiang Song, Yunfeng Bai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Mingzhe Li, Qiang Song, Yunfeng Bai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Identification of a novel cuproptosis‐related gene signature for rheumatoid arthritis—A prospective study
Han Hu, Xinyu Dou, Xiangjia Hu, et al.
The Journal of Gene Medicine (2023) Vol. 25, Iss. 11
Closed Access | Times Cited: 3
Han Hu, Xinyu Dou, Xiangjia Hu, et al.
The Journal of Gene Medicine (2023) Vol. 25, Iss. 11
Closed Access | Times Cited: 3
LncRNAs and regulated cell death in tumor cells
Yingying Wu, Xiao-Ling Wen, Yufang Xia, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Yingying Wu, Xiao-Ling Wen, Yufang Xia, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
MIR31HG, a potential lncRNA in human cancers and non-cancers
Luxi Ruan, Jing Lei, Yihang Yuan, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
Luxi Ruan, Jing Lei, Yihang Yuan, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2